SVB Leerink Maintains Outperform on Insmed, Lowers Price Target to $50
SVB Leerink analyst Joseph Schwartz maintains Insmed (NASDAQ:INSM) with a Outperform and lowers the price target from $52 to $50.
Option Care Health Sees FY22 Net Revenue of $3.90B-$3.95B Compared To Prior Range Of $3.85B-$3.95B
The company forecasts adjusted EBITDA of $336 million-$341 million compared to $330 million-$342 million expected earlier
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Insmed Earlier Reported Q2 EPS $(0.80) Beats $(0.89) Estimate, Sales $65.22M Beat $59.41M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.89) by 10.11 percent. This is a 12.09 percent increase over losses of $(0.91) per share from the same